DETAILED NOTES ON ABBV-744 BRD4 INHIBITOR MECHANISM OF ACTION

The present work examined the potential of utilizing ARV-825 and ABBV-744 to raise the effectiveness of tamoxifen or fulvestrant moreover palbociclib. ARV-825 was effective in the two p53 wild-form (WT) breast tumor cells and in cells missing practical p53 either by yourself or in combination with tamoxifen, even though the effectiveness of ABBV-74